THTX Theratechnologies, Inc.: Forvard narx/daromad multiplikatori
Theratechnologies Inc. o'sishi EGRIFTA savdolari va saratonni davolashdagi muvaffaqiyatlarga asoslangan. Tashkilotning forward P/S ko'rsatkichi va GURU.Markets grafigidagi kunlik narx harakati bozor kayfiyatini aks ettiradi, bunda 1.80 joriy darajani ko'rsatadi. Tesamorelin va SORT1 platformasi o'sishni ta'minlaydi, peptid zanjirlarining yuqori narxi va FDA patentlari esa yangi ishtirokchilar uchun kirishning sezilarli to'sig'ini yaratadi.
Theratechnologies Inc. (THTX) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- biznesning balans baholash tafsilotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning xususiy kapitalga nisbati Theratechnologies Inc.|THTX - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati theratech.com|THTX - Kompaniyaning jamlangan qarzlari|Qarzning balans qiymatiga nisbati Theratechnologies, Inc|THTX - Uzoq muddatli majburiyatlar miqdori|Kompaniyaning qisqa muddatli qarzlari Theratechnologies|Tezkor likvidlik koeffitsiyenti theratech.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
THTX - Sof daromad|Prognoz qilingan kelajakdagi foyda Theratechnologies Inc.|THTX - Kompaniya qiymatining sof foydaga nisbati|Kelajakdagi narxning foydaga nisbati Theratechnologies|THTX - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Theratechnologies, Inc|THTX - Foizlar, soliqlar va eskirishdan oldingi foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Theratechnologies|THTX - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi theratech.com|THTX - Joriy yilda bir aksiya uchun foydaning o'sish sur'ati|Keyingi yil uchun foyda o'sishi prognozi Theratechnologies Inc.
- kompaniyaning sotuvlari va tushumi statistikasi:
Kompaniyaning fundamental tahlili:Theratechnologies (THTX)
Portfelni boshqarish nuqtai nazaridan, ushbu ko'rsatkich biznesning bozor qiymatini kutilayotgan daromadga nisbatan baholaydi, bu esa stress sharoitlarida aktivning haddan tashqari qimmat baholanganligini aniqlash imkonini beradi. Taxminiy forward P/S ko'rsatkichini tahlil qilish orqali investor generik dori vositalarining yo'qligi va Theratechnologies Inc. (THTX) kompaniyasining OIV terapiyasi segmentidagi nishali barqarorligi kapitalizatsiyani qanday qo'llab-quvvatlashini, narxlash bosimi risklarini neytrallashini va multiplikatorni barqarorlashtirishini ko'rishi mumkin.
Raqobatdosh kompaniyalar
Forvard P/S multiplikatori ARGX (argenx.com)|BioNTech Group (BNTX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|ABIVAX - Forvard P/S multiplikatori|ADMA - Forvard P/S multiplikatori|Protagonist (PTGX) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori Immunovant Inc|Narxning prognoz qilingan daromadga nisbati Kiniksa Pharmaceuticals|Grifols Group (GRFS) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Adaptive Biotechnologies Corp (ADPT)|Narxning prognoz qilingan daromadga nisbati CLDX (Celldex Therapeutics)|Narxning prognoz qilingan daromadga nisbati Aurinia Pharma AUPH|Sotuvga nisbatan forvard narx BCRX|VERA: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx DNTH (Dianthus Therapeutics)|Pharvaris N.V. (PHVS) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati AbCellera Biologics (ABCL)|TRML (Tourmaline Bio Inc) - Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati PGEN (Intrexon)|Forvard narx/daromad multiplikatori PHAR (Pharming)|NKTR (Nektar) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori UPB (upstreambio.com)|ZBIO (Zenas Biopharma Inc) - Kelajakdagi narxning daromadga nisbati|IMNM - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Gossamer Bio Inc GOSS|KALV: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Septerna Pharma|PVLA (Pieris Corp) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati SVRA|Forvard P/S multiplikatori RIGL|Forvard narx/daromad multiplikatori AnaptysBio Corp ANAB|Astria Therapeutics Inc - Forvard narx/daromad multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati enGene Holdings Inc. (ENGN)|RAPT Therapeutics Inc. - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Aerovate Therapeutics, Inc.|ACRS (Aclaris Therapeutics) - Forvard narx/daromad multiplikatori|KYTX: Narxning kutilayotgan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Tiziana Life Sciences|Cabaletta Bio, Inc (CABA) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori VTYX (Ventyx Biosciences)|AVTX (Avalo Therapeutics, Inc) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori ELDN (eledon.com)|AGEN - Forvard narx/daromad multiplikatori|CLYM - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati ZURA|ATYR: Forvard P/S multiplikatori|Adagene Corp (ADAG) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori IMA|Shattuck Labs, Inc. - Kelajakdagi narxning daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Equillium Inc (EQ)|Forvard P/S multiplikatori Connect Biopharma Holdings (CNTB)|Narxning prognoz qilingan daromadga nisbati Immunic, Inc. IMUX|Forvard P/S multiplikatori Atara Biotherapeutics ATRA|IFRX - Narxning prognoz qilingan daromadga nisbati|XFOR: Narxning prognoz qilingan daromadga nisbati|ACET: Forvard P/S multiplikatori|CELU - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati inmunebio.com|Kapitalizatsiyaning prognoz qilingan daromadga nisbati BRNS (barinthusbio.com)|Forvard P/S multiplikatori KZR|Forvard P/S multiplikatori SAB Biotherapeutics, Inc (SABS)|Forvard P/S multiplikatori AKTX (Akari Therapeutics, Plc)|Forvard P/S multiplikatori enlivex.com ENLV|QTTB: Forvard narx/daromad multiplikatori|GOVX - Forvard P/S multiplikatori|Edesa Biotech Inc (EDSA) - Narxning prognoz qilingan daromadga nisbati|IBIO - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati carismatx.com|XTLB: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Bolt Biotherapeutics Inc. (BOLT)|HCW Biologics - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati aptevotherapeutics.com APVO|AIM - Forvard narx/daromad multiplikatori|Aditxt - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati GRI Bio Corporation GRI|xortx.com (XRTX) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati reshapelifesciences.com (HIND)|Narxning prognoz qilingan daromadga nisbati Revelation Bio|Bozor kapitallashuvining kelajakdagi daromadga nisbati Indaptus Therapeutics, Inc. INDP|Narxning prognoz qilingan daromadga nisbati BiondVax Pharmaceuticals (SCNI)|Forvard narx/daromad multiplikatori CalciMedica CALI|Narxning prognoz qilingan daromadga nisbati Affimed AFMD|ALLK - Forvard narx/daromad multiplikatori|HOOKIPA Pharma, Inc. - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx IGMS (igmbio.com)|ITOS (iTeos Therapeutics, Inc.) - Forvard narx/daromad multiplikatori|Ocean Biomedical Corp (OCEA) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati TC BioPharm (Holdings) PLC|Forvard P/S multiplikatori thirdharmonicbio.com
